Dr Sonnad asked panelists about the participants on payer panels who determine the cost-effectiveness of pathways.
Dr Sonnad asked panelists about the participants on payer panels who determine the cost-effectiveness of pathways.
Dr Malin said WellPoint uses an internal team of oncologists and pharmacists who collaborate on pathway recommendations. They also utilize an external advisory group of oncologists from community practices and academic centers who review the organization's outcome summaries and evidence of proposed pathways.
“We also make our pathways available on the Web so anyone can download them and there’s an e-mail address as well on the pathways themselves when you download them — any provider can provide feedback to us about the pathways,” Dr Malin said. They will monitor this feedback to determine whether certain patients may not require a pathway.
Dr Yu said that there should be ongoing and regular reviews of pathway guidelines, if they’re not already established. These are useful to determine variations and changes in pathway regimens.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Reducing Low-Value Care Is Hard, but What About Just Not Paying for It?
March 14th 2024After years of efforts to reduce low-value care, panelists at the 2024 Value-Based Insurance Design Summit proposed a new strategy: drawing a line in the sand that payers will not be on the hook for these services.
Read More